Wesley Bray
Pulmonary Disease · Marietta, GANPI 1821013087
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,009 and has fallen 85.1% since, to $150 in 2023. That places this record below the midpoint for pulmonary disease clinicians in GA, where the typical reported total is $3,789.
Across 97 payments — averaging $18.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$434
- AstraZeneca$315
- Boehringer Ingelheim$203
- Insmed, Inc.$155
- Mylan Specialty L.p.$129
- Jazz Pharmaceuticals Inc.$122
- plus $462 from 15 others
Across 2 payments — averaging $2812.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Insmed, Inc.$6K
What the payments were for
- Food & beverage$1,820100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 33 | $434 |
| AstraZeneca | 21 | $315 |
| Boehringer Ingelheim | 5 | $203 |
| Insmed, Inc. | 2 | $155 |
| Mylan Specialty L.p. | 8 | $129 |
| Jazz Pharmaceuticals Inc. | 5 | $122 |
| Grifols USA, LLC | 4 | $72 |
| Mallinckrodt Enterprises LLC | 2 | $57 |
| Philips North America LLC | 2 | $44 |
| Advanced Respiratory, Inc | 1 | $41 |
| Novartis | 2 | $37 |
| Actelion Pharmaceuticals US, Inc. | 1 | $35 |
| Electromed, Inc. | 3 | $32 |
| Ambu Inc. | 1 | $26 |
| Bayer | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| AbbVie | 1 | $18 |
| Aroa Biosurgery Incorporated | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Fisher & Paykel Healthcare Inc | 1 | $12 |
How this compares
$1,820 in reported general payments places this provider in the 30th percentile of 365 pulmonary disease providers in Georgia.
Other pulmonary disease in Marietta
- Hitendra PatelMarietta$104K
- Amyn HiraniMarietta$68K
- Brion LockMarietta$25K
- Hiren PatelMarietta$24K
- Jeffrey MichaelsonMarietta$22K
- Lawrence McDermottSavannah$963K
- Vivek SambharaGainesville$417K
- Chad MillerAustell$382K
- Nehal BhattAthens$371K
- Maria MascoloRincon$358K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.